Newgenivf Group LTD

NewGenIvf Group Limited has finalized its business combination with A SPAC I Acquisition Corp., and its shares and warrants are scheduled to commence trading on the Nasdaq Capital Market on April 4, 2024.

Wing Fung Alfred Siu, Chairman & CEO and a Director of NewGenIvf Group Ltd, reported multiple transactions in common stock on October 5, 2026.

Hei Yue Tina Fong, Chief Marketing Officer and a Director of NewGenIvf Group Ltd, reported multiple transactions in common stock on October 5, 2026.

Kong Yiu Cheung, a Director and 10% owner of NewGenIvf Group Ltd, purchased 3,722,223 shares of common stock on May 28, 2026.

NewGenIvf Group Ltd director Siu Wing Fung Alfred acquired employee share options under the company's 2024 Share Incentive Plan.

NewGenIvf Group Ltd reports the grant of employee share options to Director Hei Yue Tina Fong under the 2024 Share Incentive Plan.

HRT FINANCIAL LP has disclosed a new beneficial ownership stake in NewGenIvf Group Ltd (NIVF), acquiring 18,134 shares of common stock.

NewGenIvf Group Ltd insiders Wing Fung Alfred Siu and Hei Yue Tina Fong exercised share options for 113,702 Class B ordinary shares, increasing their beneficial ownership to 2.8%.